All the news Showing 10 of 16 articles from: Eligibility for treatmentGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources 1.2 million initiated DAA treatment for HCV between 2014 and 2020 Healio / 13 April 2022 Access To Hepatitis C Treatment And Care Among People Who Inject Drugs: Failing People Most Disproportionately Affected Hep C Coalition / 13 February 2020 Restrictions on free DAA access in many European countries contrary to guidelines and undermine HCV elimination targets, say researchers Michael Carter / 16 October 2017 The restrictions which many European countries impose on free/reimbursed access to hepatitis C virus (HCV) direct-acting antivirals (DAAs) are contrary to guidelines and undermine the World Health Organization (WHO) goal ... Results of US research suggest all people with chronic HCV need treatment to reduce mortality risk Michael Carter / 22 March 2017 All people with chronic hepatitis C virus (HCV) infection should start therapy with direct-acting antivirals, research published in the online edition of Clinical Infectious Diseases suggests. Investigators from the United States found that individuals ... EASL issues new hepatitis C treatment recommendations for all genotypes Liz Highleyman / 26 September 2016 The European Association for the Study of the Liver (EASL) released its latest recommendations on treatment of hepatitis C at a special meeting last Thursday in Paris. The updated guidelines now include highly ... HCV treatment is effective and may work as prevention for people who inject drugs Liz Highleyman / 19 September 2016 Hepatitis C treatment for people who inject drugs is as safe and effective as it is for non-drug-users – with cure rates exceeding 90% – and treating enough people in this population could ... Should we focus hepatitis C treatment on some injectors and not others? Drug & Alcohol Findings / 22 February 2016 Leading liver doctors: Hepatitis C patients must be treated American Association for the Study of Liver Diseases press release / 17 November 2015 Hepatitis C: behind new wonder drugs lies a terrible dilemma The Conversaion / 29 October 2015 One million people with hepatitis C in the US at high priority for treatment Liz Highleyman / 07 January 2015 An estimated 813,000 people with diagnosed hepatitis C in the US have undergone liver disease staging and meet the 'highest' or 'high' priority criteria for immediate treatment, according to an analysis presented ... ← First12Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive